2019      Groom KM, McCowan LM, Mackay LK, Lee AC, Gardener G, Unterscheider J, Sekar R, Dickinson JE, Muller P, Reid RA, Watson D, Welsh A, Marlow J, Walker SP, Hyett J, Morris J, Stone PR, Baker PN. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early‐onset fetal growth restriction. BJOG. 2019;126(8):997-1006. https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.15658

2019      Cartwright RD, Crowther CA, Anderson PJ, Harding JE, Doyle LW, McKinlay CJD. Association of Fetal Growth Restriction with neurocognitive function after repeated antenatal betamethasone treatment vs placebo: Secondary analysis of the ACTORDS Randomized Clinical Trial. JAMA Netw Open. 2019 Feb 1;2(2):e187636. doi: 10.1001/jamanetworkopen.2018.7636. https://www.ncbi.nlm.nih.gov/pubmed/30707225

2017      Groom KM, McCowan LM, Mackay LK, Lee AC, Said JM, Kane SC, et al. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial. Am J Obstet Gynecol. 2017 Mar;216(3):296.e1-296.e14. doi: 10.1016/j.ajog.2017.01.014. Epub 2017 Jan 30. http://www.ncbi.nlm.nih.gov/pubmed/28153659

2017      Pels A, Kenny LC, Alfirevic Z, Baker PN, von Dadelszen P, Gluud C, et al. STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials. BMC Pregnancy Childbirth. 2017;17(1):440. BMC Pregnancy Childbirth. 2017 Dec 28;17(1):440. doi: 10.1186/s12884-017-1594-z. http://www.ncbi.nlm.nih.gov/pubmed/29282009